Literature DB >> 7200602

Is myelomeningocele a disappearing disease?

S C Stein, J G Feldman, M Friedlander, R J Klein.   

Abstract

The incidence of major congenital anomalies of the central nervous system was determined in a study of more than 233,000 births in Brooklyn, New York hospitals during the years 1968 to 1979. Anencephaly, myelomeningocele, and hydrocephalus occurred at frequencies of 47.1, 42.4, and 49.3 cases per 100,000 total births, respectively. During the 12 years of the study, the incidence of myelomeningocele decreased at a linear rate of approximately 4.6 cases per 100,000 births per year. A review of comparable reports on births in the northeastern region of the United States shows that a relatively consistent linear decline in myelomeningocele incidence has been proceeding at this rate for the past 50 years. It is concluded that minor local fluctuations and variability in data collection have obscured the steady decrease in occurrence. No significant declines were seen in the incidence rates of anencephaly or hydrocephalus, nor were uniform secular trends for these anomalies evident from previous reports. Epidemiologic differences between myelomeningocele and anencephaly are noted and their common etiology is questioned.

Entities:  

Mesh:

Year:  1982        PMID: 7200602

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Current trends in the prevalence at birth of neural tube defects in Singapore.

Authors:  K C Tan; N K Ho
Journal:  J Med Genet       Date:  1989-06       Impact factor: 6.318

2.  Rehabilitating the neurogenic bladder: the role of artificial neural reflex pathways in children with spina bifida.

Authors:  Sarah M Lambert; Kenneth I Glassberg; Richard C Anderson
Journal:  Curr Urol Rep       Date:  2006-03       Impact factor: 3.092

3.  When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?

Authors:  L L Tosi; A S Detsky; D P Roye; M L Morden
Journal:  CMAJ       Date:  1987-02-01       Impact factor: 8.262

4.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  The fetal spine.

Authors:  P D Russ; D H Pretorius; M L Manco-Johnson; C M Rumack
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

6.  Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.

Authors:  A Chan; E F Robertson; E A Haan; R J Keane; E Ranieri; A Carney
Journal:  BMJ       Date:  1993-09-18

7.  Time trends of spina bifida in Sweden 1947-81.

Authors:  B Källén; E Löfkvist
Journal:  J Epidemiol Community Health       Date:  1984-06       Impact factor: 3.710

8.  Spina bifida and anencephaly: fewer patients, more problems.

Authors:  I Leck
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

9.  Epidemiology of neural tube defects in Germany.

Authors:  M Koch; W Fuhrmann
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Emergent care patterns in patients with spina bifida: a case-control study.

Authors:  Hsin-Hsiao S Wang; John S Wiener; Sherry S Ross; Jonathan C Routh
Journal:  J Urol       Date:  2014-07-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.